Showing results (1-10 of 403) with videos related to

Sort By:
Pageof 41
Digestive Diseases (Basel, Switzerland)|January 1, 1992
Clotting abnormalities in chronic liver diseaseF Violi, D Ferro, C Quintarelli, et al.
Hepatology (Baltimore, Md.)|April 1, 1992
Hyperfibrinolysis increases the risk of gastrointestinal hemorrhage in patients with advanced cirrhosisF Violi, D Ferro, S Basili, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1989
Inhibition of tissue plasminogen activator inhibitor by defibrotide in atherosclerotic patientsF Violi, D Ferro, C Alessandri, et al.
European Journal of Clinical Pharmacology|January 1, 1992
Effect of oral defibrotide on tissue-plasminogen activator and tissue-plasminogen activator inhibitor balanceF Violi, D Ferro, M Saliola, et al.
Journal of Clinical Pathology|September 1, 1986
Hageman factor, high molecular weight kininogen, and prekallikrein in chronic liver diseaseC Cordova, F Violi, C Alessandri, et al.
Thrombosis and Haemostasis|April 12, 1990
Dilute aPTT prolongation by antiphospholipid antibodies in patients with liver cirrhosisF Violi, D Ferro, C Quintarelli, et al.
Journal of Clinical Pathology|December 1, 1989
Interrelation between factor VII, prekallikrein, and hyperfibrinolysis in advanced cirrhosisF Violi, C Alessandri, D Ferro, et al.
BMJ (Clinical Research Ed.)|April 28, 1990
Tissue plasminogen activator inhibitor in patients with systemic lupus erythematosus and thrombosisF Violi, D Ferro, G Valesini, et al.
American Journal of Clinical Pathology|May 1, 1986
Prekallikrein and factor VII as prognostic indexes of liver failureC Cordova, F Violi, C Alessandri, et al.
Pageof 41